These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 19125962)
1. Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease. Guaraldi G; Ventura P; Garlassi E; Orlando G; Squillace N; Nardini G; Stentarelli C; Zona S; Marchini S; Moriondo V; Tebas P HIV Med; 2009 Jan; 10(1):28-34. PubMed ID: 19125962 [TBL] [Abstract][Full Text] [Related]
2. Liver triglyceride content in HIV-1-infected patients on combination antiretroviral therapy studied with 1H-MR spectroscopy. Moreno-Torres A; Domingo P; Pujol J; Blanco-Vaca F; Arroyo JA; Sambeat MA Antivir Ther; 2007; 12(2):195-203. PubMed ID: 17503662 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia. Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343 [TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors. Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884 [TBL] [Abstract][Full Text] [Related]
5. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients. Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696 [TBL] [Abstract][Full Text] [Related]
6. Incidence of and risk factors for insulin resistance in treatment-naive HIV-infected patients 48 weeks after starting highly active antiretroviral therapy. Palacios R; Merchante N; Macias J; González M; Castillo J; Ruiz J; Márquez M; Gómez-Mateos J; Pineda JA; Santos J Antivir Ther; 2006; 11(4):529-35. PubMed ID: 16856627 [TBL] [Abstract][Full Text] [Related]
7. Is plasma homocysteine level associated with metabolic syndrome components in adolescents? Budak N; Yazici C; Oztürk A; Bayram F; Mazicioğlu MM; Kurtoglu S Metab Syndr Relat Disord; 2009 Aug; 7(4):357-62. PubMed ID: 19558275 [TBL] [Abstract][Full Text] [Related]
8. Association of apolipoproteins C3 and E with metabolic changes in HIV-infected adults treated with a protease-inhibitor-containing antiretroviral therapy. Bard JM; Lassalle R; Capeau J; Bach-Ngohou K; Nazih-Sanderson F; Rémy G; Reynes J; Ecobichon JL; Savès M; Raffi F; Antivir Ther; 2006; 11(3):361-70. PubMed ID: 16759053 [TBL] [Abstract][Full Text] [Related]
9. Plasma homocysteine levels in HIV-infected men with and without lipodystrophy. Deminice R; Vassimon HS; Machado AA; de Paula FJ; Monteiro JP; Jordao AA Nutrition; 2013; 29(11-12):1326-30. PubMed ID: 24045000 [TBL] [Abstract][Full Text] [Related]
10. Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism. Altinova AE; Törüner FB; Aktürk M; Bukan N; Cakir N; Ayvaz G; Arslan M Clin Endocrinol (Oxf); 2006 Oct; 65(4):530-5. PubMed ID: 16984248 [TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia as a cardiovascular risk factor in Indian women: determinants and directionality. Pandey SN; Vaidya AD; Vaidya RA; Talwalkar S J Assoc Physicians India; 2006 Oct; 54():769-74. PubMed ID: 17214272 [TBL] [Abstract][Full Text] [Related]
12. Hyperhomocysteinaemia is associated with the rate of abdominal aortic aneurysm expansion. Halazun KJ; Bofkin KA; Asthana S; Evans C; Henderson M; Spark JI Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):391-4; discussion 395-6. PubMed ID: 17164089 [TBL] [Abstract][Full Text] [Related]
13. Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy. Estrada V; Martínez-Larrad MT; González-Sánchez JL; de Villar NG; Zabena C; Fernández C; Serrano-Ríos M Metabolism; 2006 Jul; 55(7):940-5. PubMed ID: 16784968 [TBL] [Abstract][Full Text] [Related]
14. Hyperhomocysteinemia correlates with insulin resistance and low-grade systemic inflammation in obese prepubertal children. Martos R; Valle M; Morales R; Cañete R; Gavilan MI; Sánchez-Margalet V Metabolism; 2006 Jan; 55(1):72-7. PubMed ID: 16324922 [TBL] [Abstract][Full Text] [Related]
15. Endothelial function is impaired in HIV-infected patients with lipodystrophy. Masiá M; Padilla S; García N; Jarrin I; Bernal E; López N; Hernández I; Gutiérrez F Antivir Ther; 2010; 15(1):101-10. PubMed ID: 20167996 [TBL] [Abstract][Full Text] [Related]
16. Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: results from the SIMONE study. De Socio GV; Parruti G; Quirino T; Ricci E; Schillaci G; Adriani B; Marconi P; Franzetti M; Martinelli C; Vichi F; Penco G; Sfara C; Madeddu G; Bonfanti P; J Infect; 2008 Jul; 57(1):33-40. PubMed ID: 18436307 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study. Glass TR; Ungsedhapand C; Wolbers M; Weber R; Vernazza PL; Rickenbach M; Furrer H; Bernasconi E; Cavassini M; Hirschel B; Battegay M; Bucher HC; HIV Med; 2006 Sep; 7(6):404-10. PubMed ID: 16903986 [TBL] [Abstract][Full Text] [Related]
19. Association of homocysteinemia with high concentrations of serum insulin and uric acid in Brazilian subjects with metabolic syndrome genotyped for C677T polymorphism in the methylenetetrahydrofolate reductase gene. Uehara SK; Rosa G Nutr Res; 2008 Nov; 28(11):760-6. PubMed ID: 19083485 [TBL] [Abstract][Full Text] [Related]
20. Early changes in adipokine levels and baseline limb fat may predict HIV lipoatrophy over 2 years following initiation of antiretroviral therapy. Calmy A; Carey D; Mallon PW; Wand H; Law M; Cooper DA; Carr A; ; HIV Med; 2008 Feb; 9(2):101-10. PubMed ID: 18257772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]